May 1-3, 2017 • San Diego, California
Gemma Moore joined Edwards Lifesciences in early 2014 as Vice President of International Regulatory Affairs. Currently, Gemma is responsible for strategic and operational direction for the product registration portfolio in the international markets and establishing a regulatory affairs infrastructure in these markets. Gemma brings more than 20 years of experience working in the international markets, especially in Asia Pacific clinical affairs, as well as regulatory affairs. Gemma also has extensive experience in teaching clinical research throughout Asia Pacific.
Prior to working at Edwards Lifesciences, Gemma was Vice President of International Emerging Markets Regulatory and Clinical Affairs for Smith & Nephew. This is where she established the Regulatory Affairs infrastructure in China and other emerging market counties as well conducting regulatory due diligence for merger and acquisition activities in these markets. Gemma spent 10 years in Medical Research at the NHMRC Clinical Trial Center, University of Sydney a methodology unit in clinical trials. Gemma holds degrees from The Australian Catholic University, Macquarie University, Wollongong University and The University of Sydney with degrees in neurophysiology, neuropsychology and a Master’s degree in Public Health.